• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大肝癌趋势:简要临床和流行病学概述。

Canadian trends in liver cancer: a brief clinical and epidemiologic overview.

机构信息

Cancer Control Policy, Canadian Cancer Society, Toronto, ON.

出版信息

Curr Oncol. 2013 Feb;20(1):e40-3. doi: 10.3747/co.20.1190.

DOI:10.3747/co.20.1190
PMID:23443230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3557341/
Abstract

Although primary liver cancer is rare, its incidence rate has been rising quickly in Canada, more than tripling since the early 1980s. This cancer is more common in men than women, and the age-specific incidence rates in men have been increasing significantly in all age groups from 40 years of age onward. The death rate has followed a similar upward trajectory, in part because of the low 5-year survival rate of 18% in both sexes. Infection with the hepatitis B or C virus continues to be the most common risk factor, but other factors may also play a role. Risk reduction strategies, such as viral hepatitis screening, have been recommended in other countries and warrant consideration in Canada as part of a coordinated strategy of disease prevention and control.

摘要

尽管原发性肝癌较为罕见,但在加拿大,其发病率自 20 世纪 80 年代初以来迅速上升,增幅超过两倍。这种癌症在男性中比女性更为常见,而且从 40 岁开始,所有年龄段的男性的年龄特异性发病率都在显著上升。死亡率也呈现出类似的上升趋势,部分原因是两性的 5 年生存率均较低,仅为 18%。乙型肝炎或丙型肝炎病毒感染仍然是最常见的危险因素,但其他因素也可能起作用。在其他国家,已经推荐了降低风险的策略,如病毒性肝炎筛查,加拿大也应该考虑作为疾病预防和控制的协调战略的一部分。

相似文献

1
Canadian trends in liver cancer: a brief clinical and epidemiologic overview.加拿大肝癌趋势:简要临床和流行病学概述。
Curr Oncol. 2013 Feb;20(1):e40-3. doi: 10.3747/co.20.1190.
2
Primary liver cancer: worldwide incidence and trends.原发性肝癌:全球发病率及趋势
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16. doi: 10.1053/j.gastro.2004.09.011.
3
Liver cancer and its prevention.肝癌及其预防。
Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):244-50.
4
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
5
Age-standardized cancer-incidence trends in Canada, 1971-2015.加拿大 1971-2015 年标准化癌症发病率趋势。
CMAJ. 2019 Nov 18;191(46):E1262-E1273. doi: 10.1503/cmaj.190355.
6
Prostate cancer trends in Canada: rising incidence or increased detection?加拿大前列腺癌的趋势:发病率上升还是检测增加?
CMAJ. 1993 Sep 1;149(5):617-24.
7
Epidemiological study of hepatitis B virus infection in Manitoba, Canada, 1992-2003.1992 - 2003年加拿大曼尼托巴省乙型肝炎病毒感染的流行病学研究。
Eur J Clin Microbiol Infect Dis. 2005 Jul;24(7):464-70. doi: 10.1007/s10096-005-1350-6.
8
Trends in mortality from primary liver cancer in Europe.欧洲原发性肝癌的死亡率趋势。
Eur J Cancer. 2000 May;36(7):909-15. doi: 10.1016/s0959-8049(00)00052-6.
9
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.特定病因引起的原发性肝癌发病率趋势:2016 年全球疾病负担研究结果及其对肝癌预防的意义。
J Hepatol. 2019 Apr;70(4):674-683. doi: 10.1016/j.jhep.2018.12.001. Epub 2018 Dec 11.
10
Surveillance for acute viral hepatitis--United States, 2005.2005年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2007 Mar 16;56(3):1-24.

引用本文的文献

1
Stigmatization of drinking patients with liver cancer: The role of socioeconomic status.肝癌饮酒患者的污名化:社会经济地位的作用。
Heliyon. 2024 Apr 2;10(7):e29105. doi: 10.1016/j.heliyon.2024.e29105. eCollection 2024 Apr 15.
2
Criteria to define rare diseases and orphan drugs: a systematic review protocol.定义罕见病和孤儿药的标准:系统评价方案。
BMJ Open. 2022 Jul 29;12(7):e062126. doi: 10.1136/bmjopen-2022-062126.
3
Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma.α 放射栓塞在肝癌动物模型中的初步评价。
PLoS One. 2022 Jan 21;17(1):e0261982. doi: 10.1371/journal.pone.0261982. eCollection 2022.
4
Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database.索拉非尼起始剂量和剂量强度对肝癌患者生存的影响:来自加拿大多中心数据库的结果。
Cancer Med. 2020 Jul;9(14):4918-4928. doi: 10.1002/cam4.3228. Epub 2020 Jun 11.
5
Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.1997年至2016年中国肝癌的疾病负担:一项基于全球疾病负担的观察性研究
BMJ Open. 2019 Apr 23;9(4):e025613. doi: 10.1136/bmjopen-2018-025613.
6
Hospital stays for hepatitis B or C virus infection or primary liver cancer among immigrants: a census-linked population-based cohort study.移民中因感染乙型或丙型肝炎病毒或原发性肝癌而住院的情况:一项基于人口普查的队列研究。
CMAJ Open. 2016 Apr 28;4(2):E162-8. doi: 10.9778/cmajo.20150117. eCollection 2016 Apr-Jun.
7
Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986-2007.1986 - 2007年加拿大肾癌的发病率、死亡率及生存率趋势
Cancer Causes Control. 2014 Oct;25(10):1271-81. doi: 10.1007/s10552-014-0427-x. Epub 2014 Jul 18.

本文引用的文献

1
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.推荐意见:识别 1945 年至 1965 年期间出生人群的慢性丙型肝炎病毒感染。
MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32.
2
Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.多学科加拿大共识推荐意见:肝细胞癌的管理与治疗。
Curr Oncol. 2011 Oct;18(5):228-40. doi: 10.3747/co.v18i5.952.
3
International trends in liver cancer incidence rates.全球肝癌发病率趋势。
Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8. doi: 10.1158/1055-9965.EPI-11-0643. Epub 2011 Sep 15.
4
The global epidemiology of hepatocellular carcinoma: present and future.肝细胞癌的全球流行病学:现状与未来。
Clin Liver Dis. 2011 May;15(2):223-43, vii-x. doi: 10.1016/j.cld.2011.03.006.
5
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.肝细胞癌的发病率和流行病学:全球和区域视角。
Oncologist. 2010;15 Suppl 4:5-13. doi: 10.1634/theoncologist.2010-S4-05.
6
An update on cancer survival.癌症生存状况更新。
Health Rep. 2010 Sep;21(3):55-60.
7
Non-viral causes of hepatocellular carcinoma.非病毒性肝癌病因。
World J Gastroenterol. 2010 Aug 7;16(29):3603-15. doi: 10.3748/wjg.v16.i29.3603.
8
Global hepatitis, migration and its impact on Western healthcare.全球肝炎、移民及其对西方医疗保健的影响。
Gut. 2010 Aug;59(8):1009-11. doi: 10.1136/gut.2009.206763.
9
The changing pattern of epidemiology in hepatocellular carcinoma.肝细胞癌流行病学的变化模式。
Dig Liver Dis. 2010 Jul;42 Suppl 3(Suppl 3):S206-14. doi: 10.1016/S1590-8658(10)60507-5.
10
Evidence-based clinical guidelines for immigrants and refugees.针对移民和难民的循证临床指南。
CMAJ. 2011 Sep 6;183(12):E824-925. doi: 10.1503/cmaj.090313. Epub 2010 Jun 7.